Neoatherosclerosis prediction using plaque markers in intravascular optical coherence tomography images.
OCTOPUS
fibrous cap surface area
intravascular optical coherence tomography
neoatherosclerosis
plaque characteristics
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
10
2022
accepted:
29
11
2022
entrez:
2
1
2023
pubmed:
3
1
2023
medline:
3
1
2023
Statut:
epublish
Résumé
In-stent neoatherosclerosis has emerged as a crucial factor in post-stent complications including late in-stent restenosis and very late stent thrombosis. In this study, we investigated the ability of quantitative plaque characteristics from intravascular optical coherence tomography (IVOCT) images taken just prior to stent implantation to predict neoatherosclerosis after implantation. This was a sub-study of the TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer with Optical Coherence Tomography (TRANSFORM-OCT) trial. Images were obtained before and 18 months after stent implantation. Final analysis included images of 180 lesions from 90 patients; each patient had images of two lesions in different coronary arteries. A total of 17 IVOCT plaque features, including lesion length, lumen (e.g., area and diameter); calcium (e.g., angle and thickness); and fibrous cap (FC) features (e.g., thickness, surface area, and burden), were automatically extracted from the baseline IVOCT images before stenting using dedicated software developed by our group (OCTOPUS). The predictive value of baseline IVOCT plaque features for neoatherosclerosis development after stent implantation was assessed using univariate/multivariate logistic regression and receiver operating characteristic (ROC) analyses. Follow-up IVOCT identified stents with ( Post-stent neoatherosclerosis can be predicted by quantitative IVOCT imaging of plaque characteristics prior to stent implantation. Our findings highlight the additional clinical benefits of utilizing IVOCT imaging in the catheterization laboratory to inform treatment decision-making and improve outcomes.
Identifiants
pubmed: 36588557
doi: 10.3389/fcvm.2022.1079046
pmc: PMC9794759
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1079046Informations de copyright
Copyright © 2022 Lee, Pereira, Motairek, Kim, Zimin, Dallan, Hoori, Al-Kindi, Guagliumi and Wilson.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Biomed Opt Express. 2012 Jun 1;3(6):1413-26
pubmed: 22741086
JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55
pubmed: 23153915
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
Heliyon. 2023 Feb 01;9(2):e13396
pubmed: 36816277
Circ Cardiovasc Interv. 2012 Feb 1;5(1):47-54
pubmed: 22253359
J Invasive Cardiol. 2012 Mar;24(3):116-20
pubmed: 22388303
Cardiovasc Revasc Med. 2022 Oct;43:62-70
pubmed: 35597721
Biomed Opt Express. 2019 Nov 25;10(12):6497-6515
pubmed: 31853413
IEEE Access. 2021;9:37273-37280
pubmed: 33828934
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1467-1478
pubmed: 30093052
J Cardiol. 2021 Jul;78(1):58-65
pubmed: 33516636
J Am Coll Cardiol. 2012 Jun 5;59(23):2051-7
pubmed: 22651862
EuroIntervention. 2016 Dec 10;12(11):e1366-e1374
pubmed: 26690315
Cardiology. 2014;128(1):34-40
pubmed: 24514877
Circ Cardiovasc Interv. 2014 Apr;7(2):168-79
pubmed: 24550439
IEEE Access. 2020;8:225581-225593
pubmed: 33598377
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2054-61
pubmed: 16037567
JACC Cardiovasc Imaging. 2013 Oct;6(10):1121-1123
pubmed: 24135328
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350
pubmed: 30025727
Circulation. 2007 Nov 20;116(21):2391-8
pubmed: 17984377
Cardiovasc Revasc Med. 2021 Mar;24:48-54
pubmed: 32981855
Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):276-84
pubmed: 22945378
Life (Basel). 2022 Mar 08;12(3):
pubmed: 35330144
Eur Heart J. 2018 Jul 7;39(26):2448-2456
pubmed: 29788263
J Am Coll Cardiol. 2008 Sep 30;52(14):1134-40
pubmed: 18804739
Biomed Opt Express. 2019 May 16;10(6):2809-2828
pubmed: 31259053
J Am Coll Cardiol. 2011 Mar 15;57(11):1314-22
pubmed: 21376502
Herz. 2015 Sep;40(6):845-54
pubmed: 26259732
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Am Heart J. 2014 Jun;167(6):884-92.e2
pubmed: 24890539
J Korean Med Sci. 2017 Jul;32(7):1056-1061
pubmed: 28581259
Circ Cardiovasc Interv. 2010 Oct;3(5):468-75
pubmed: 20823392
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):660-6
pubmed: 22798521
Sci Rep. 2023 Oct 23;13(1):18110
pubmed: 37872298
Circ Cardiovasc Interv. 2015 Feb;8(2):e001878
pubmed: 25613674
Heart. 2014 Jan;100(2):153-9
pubmed: 24270744
J Med Imaging (Bellingham). 2018 Oct;5(4):044504
pubmed: 30525060
Proc SPIE Int Soc Opt Eng. 2022 Feb-Mar;12034:
pubmed: 36465096
Am J Cardiol. 2014 Oct 1;114(7):1003-10
pubmed: 25118124
Sci Rep. 2022 Dec 12;12(1):21454
pubmed: 36509806
Am J Cardiol. 2012 Oct 1;110(7):933-9
pubmed: 22727183
Am Heart J. 2012 Apr;163(4):608-16
pubmed: 22520527
Bioengineering (Basel). 2022 Nov 03;9(11):
pubmed: 36354559
JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74
pubmed: 24355117
Coron Artery Dis. 2013 Mar;24(2):95-101
pubmed: 23363984
Sci Rep. 2020 Feb 7;10(1):2150
pubmed: 32034252
Eur Heart J. 2010 Feb;31(4):401-15
pubmed: 19892716
Circulation. 2022 Jan 18;145(3):e4-e17
pubmed: 34882436
EuroIntervention. 2021 Aug 27;17(6):489-496
pubmed: 32985411
Int J Cardiovasc Imaging. 2012 Aug;28(6):1281-7
pubmed: 21858655
J Med Imaging (Bellingham). 2019 Oct;6(4):045002
pubmed: 31903407
Circulation. 2014 Jan 14;129(2):211-23
pubmed: 24163064
Eur Heart J. 2015 Aug 21;36(32):2147-59
pubmed: 25994755
Atherosclerosis. 2014 Nov;237(1):23-9
pubmed: 25190308
Sci Rep. 2020 Feb 13;10(1):2596
pubmed: 32054895
Am J Cardiol. 2013 Nov 1;112(9):1315-21
pubmed: 23891431
Circ Cardiovasc Interv. 2019 Aug;12(8):e008024
pubmed: 31525083
J Am Coll Cardiol. 2008 Jul 29;52(5):333-42
pubmed: 18652940